John E Macor Selected Research

John E Macor Research Topics

Disease

12	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 08/2008
9	Migraine Disorders (Migraine) 01/2021 - 08/2008
9	Schizophrenia (Dementia Praecox) 03/2017 - 04/2014
5	Neuralgia (Stump Neuralgia) 10/2022 - 01/2016
4	Cognitive Dysfunction 03/2017 - 02/2016
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 11/2019
3	Inflammation (Inflammations) 06/2020 - 03/2003
3	Parkinson Disease (Parkinson's Disease) 03/2019 - 01/2016
3	Hypertension (High Blood Pressure) 01/2005 - 03/2003
2	Pain (Aches) 12/2021 - 01/2016
2	Major Depressive Disorder (Major Depressive Disorders) 05/2018 - 12/2017
2	Neoplasms (Cancer) 02/2016 - 05/2015
2	Erectile Dysfunction 03/2004 - 02/2003
1	Arthritis (Polyarthritis) 12/2020
1	Demyelinating Diseases (Demyelinating Disease) 10/2020
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 10/2020
1	Treatment-Resistant Depressive Disorder 12/2017
1	Mood Disorders (Mood Disorder) 02/2016
1	Vomiting 02/2016
1	Diarrhea 02/2016
1	Hyperalgesia 01/2016
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2016
1	Neurobehavioral Manifestations 01/2016
1	Acute Pain 01/2016
1	Stroke (Strokes) 05/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 05/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2015
1	Dementia (Dementias) 01/2014
1	Hypersensitivity (Allergy) 10/2006
1	Melanoma (Melanoma, Malignant) 10/2006
1	Pneumonia (Pneumonitis) 10/2006

Drug/Important Bio-Agent (IBA)

7	Calcitonin Gene-Related PeptideIBA 01/2021 - 08/2008
6	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2021 - 04/2012
5	Phosphotransferases (Kinase)IBA 10/2022 - 01/2016
5	Peptides (Polypeptides)IBA 01/2016 - 04/2004
4	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 07/2016 - 08/2008
4	Amyloid (Amyloid Fibrils)IBA 03/2016 - 03/2013
3	Proteins (Proteins, Gene)FDA Link 10/2022 - 03/2013
3	AminesIBA 01/2022 - 01/2016
3	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2021 - 08/2008
3	ProdrugsIBA 12/2020 - 12/2017
3	Metabotropic Glutamate 5 ReceptorIBA 01/2017 - 12/2016
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2016 - 04/2014
2	EthersIBA 01/2022 - 01/2017
2	AmidesIBA 12/2021 - 04/2012
2	Formaldehyde (Formol)FDA Link 12/2021 - 01/2016
2	Phosphates (Orthophosphate)IBA 12/2020 - 12/2017
2	Biological ProductsIBA 12/2020 - 11/2019
2	EnzymesIBA 10/2020 - 08/2008
2	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2017 - 01/2017
2	BMS-933043IBA 03/2017 - 01/2016
2	Glycogen Synthase Kinase 3IBA 02/2016 - 05/2015
2	AcidsIBA 01/2016 - 01/2014
2	piperidineIBA 06/2013 - 12/2012
2	4- (8- fluoro- 2- oxo- 1,2- dihydroquinazolin- 3(4H)- yl)- N- (3- (7- methyl- 1H- indazol- 5- yl)- 1- oxo- 1- (4- (piperidin- 1- yl)piperidin- 1- yl)propan- 2- yl)piperidine- 1- carboxamideIBA 04/2012 - 08/2008
2	Type 1 Melanocortin ReceptorIBA 10/2006 - 03/2003
2	Angiotensin IIIBA 04/2004 - 03/2003
2	Phosphodiesterase 5 InhibitorsIBA 03/2004 - 02/2003
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2022
1	pyridazineIBA 01/2021
1	LigandsIBA 01/2021
1	CollagenIBA 12/2020
1	mouse interleukin-6IBA 12/2020
1	Methanol (Carbinol)IBA 12/2020
1	Sulfoglycosphingolipids (Sulfatides)IBA 10/2020
1	Cerebroside-Sulfatase (Arylsulfatase A)IBA 10/2020
1	Imiquimod (Aldara)FDA LinkGeneric 06/2020
1	VU0652957IBA 03/2019
1	BMS-986163IBA 05/2018
1	benzocycloheptapyridineIBA 01/2018
1	Pharmaceutical PreparationsIBA 12/2017
1	Glutamic Acid (Glutamate)FDA Link 12/2017
1	N-Methylaspartate (NMDA)IBA 12/2017
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2017
1	O-(glucuronic acid 2- sulfate)- (1- - 4)- O- (2,5)- anhydromannitol 6-sulfateIBA 07/2016
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 03/2016
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 03/2016
1	NeuropeptidesIBA 02/2016
1	Cholinergic Agents (Cholinergics)IBA 02/2016
1	xanomelineIBA 02/2016
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 02/2016
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 01/2016
1	octaneIBA 01/2016
1	metabotropic glutamate receptor 4IBA 01/2016
1	Streptozocin (Streptozotocin)FDA Link 01/2016
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2016
1	Glycogen Synthase (Synthase I)IBA 05/2015
1	N- (3- (7- methyl- 1H- indazol- 5- yl)- 1- (4- (1- methylpiperidin- 4- yl)- 1- oxopropan- 2- yl))- 4- (2- oxo- 1,2- dihydroquinolin- 3- yl)piperidine- 1- carboxamideIBA 06/2013
1	Tryptamines (Triptans)IBA 06/2013
1	pyridineIBA 04/2012
1	BMS-846372IBA 04/2012
1	SulfonamidesIBA 06/2010
1	Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA 08/2008
1	Amyloid beta-PeptidesIBA 08/2008
1	NF-kappa B (NF-kB)IBA 10/2006
1	BMS-470539IBA 10/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2006

Therapy/Procedure

1	Ligation 01/2016
1	Therapeutics 06/2013